GNPX
Genprex Inc
NASDAQ: GNPX · HEALTHCARE · BIOTECHNOLOGY
$0.98
+12.07% today
Updated 2026-04-30
Market cap
$8.41M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-17.40
Dividend yield
—
52W range
$1 – $55
Volume
1.1M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$7.50
+669.23%
12-Month target
$4.25
+335.90%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-4.10M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-23.74M | $-30.86M | $-21.11M | $-16.23M | $-3.79M |
| EPS | — | — | — | — | $-17.40 |
| Free cash flow | $-17.78M | $-24.81M | $-17.15M | $-15.31M | $-4.10M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Genprex Inc trades at $0.98. Our Smart Value Score of 23/100 indicates the stock is weak.
Frequently asked questions
What is Genprex Inc's stock price?
Genprex Inc (GNPX) trades at $0.98.
Is Genprex Inc overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell).
What is the price target of Genprex Inc (GNPX)?
The analyst target price is $7.50, representing +669.2% upside from the current price of $0.98.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-338.70%
Beta-0.67
50D MA$1.70
200D MA$6.00
Shares out0.01B
Float0.01B
Short ratio—
Avg volume1.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—